Prakiraan wutah bathi resik saben saham kanggo taun ngarep Harpoon Therapeutics, Inc. (HARP)
Harpoon Therapeutics (HARP) confirmed its expertise in T-cell therapy through a deal with Merck. High R&D costs and strict regulatory oversight create significant barriers to entry. The forward earnings per share growth forecast reflects analyst expectations, with the indicator level standing at -173.10. Meanwhile, the company effectively utilizes third-party testing centers while maintaining full control over its patents.
Rincian metrik lan analitis perusahaan Harpoon Tx (HARP)
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- rincian nilai buku perusahaan:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Harpoon Therapeutics|HARP - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Harpoon Therapeutics Inc|HARP - Tanggungan utang total perusahaan|Utang marang nilai buku Harpoon Therapeutics|HARP - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan Harpoon Therapeutics|Rasio cepet harpoontx.com
- statistik bathi lan rasio pasar:
HARP - Penghasilan resik perusahaan|Bathi sing dikarepake Harpoon Therapeutics|HARP - Nilai perusahaan marang bathi resik|Pangali Forward P/E harpoontx.com|HARP - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Harpoon Therapeutics, Inc.|HARP - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Harpoon Therapeutics|HARP - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan harpoontx.com|HARP - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Harpoon Therapeutics
- data pendapatan lan penerimaan dodolan:
Analisis kabeh metrik perusahaan:Harpoon Tx
Harpoon Therapeutics (HARP) specialized in the development of T-cell immunotherapeutic platforms, although pre-commercial stage risks were mitigated through a merger with a pharmaceutical behemoth. By analyzing the history of forward earnings per share valuations, an investor tracks the dynamics of consensus EPS forecasts, which allows for the timely identification of shifts in market expectations and the avoidance of purchasing overvalued assets at the peak of analyst optimism.
Pesaing langsung
Prakiraan wutah bathi resik saben saham kanggo taun ngarep immunitybio.com|Prakiraan wutah bathi saben saham kanggo taun ngarep immunocore.com (IMCR)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Janux Therapeutics Inc (JANX)|Prakiraan wutah bathi saben saham kanggo taun ngarep Arcus Bio RCUS|Zymeworks Inc - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Tango Therapeutics Corp TNGX|IOVA - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMTX (immatics.com) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Xencor Inc. (XNCR) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Compass Bio (CMPX)|Prakiraan wutah bathi saben saham kanggo taun ngarep REPL|LYEL - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep IPHA (Innate Pharma, S.A.)|Proyeksi tambahing bathi saben saham ing taun ngarep PYXS|Prakiraan wutah bathi kanggo taun ngarep CGEN (Compugen Ltd.)|Dinamika bathi saben saham sing diarepake ing taun ngarep IOBT|sutrobio.com - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep MiNK Therapeutics, Inc|Werewolf (HOWL) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Immix Biopharma Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|ALXO (alxoncology.com) - Prakiraan wutah bathi kanggo taun ngarep|Cue Biopharma, Inc. - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep pdsbiotech.com (PDSB)|SONN: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|MAIA Biotech - Prakiraan wutah bathi saben saham kanggo taun ngarep|liminatuspharma.com (LIMN) - Prakiraan wutah bathi resik saben saham ing taun ngarep|LVTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NXTC (NextCure) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|LPTX: Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep INTS|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Sensei Biotherapeutics, Inc.|Prakiraan wutah bathi resik saben saham ing taun ngarep therivabio.com TOVX|Prakiraan wutah bathi saben saham kanggo taun ngarep GRTS (Gritstone bio, Inc.)|Prakiraan wutah bathi kanggo taun ngarep Kineta Bio (KA)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep NexImmune Corporation NEXI|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep turnstonebio.com (TSBX)|VCNX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep
